Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

670 Articles

Jon C. Ogg | Oct 18, 2017 at 2:10 PM EDT

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

With Eli Lilly making a huge headline investment in a cancer vaccine, 24/7 Wall St. wanted to look under the…

Chris Lange | Oct 11, 2017 at 10:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The September 29 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Oct 10, 2017 at 9:12 AM EDT

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

The top analyst upgrades, downgrades and other research calls from Tuesday include Alphabet, Check Point Software, Chesapeake Energy, Chevron, Intel,…

Chris Lange | Sep 27, 2017 at 9:00 AM EDT

Major Pharma Short Interest Piles On

The September 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 26, 2017 at 12:10 PM EDT

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

If there is one cure or one treatment that could be the proverbial Holy Grail for a pharmaceutical or biotech…

Jon C. Ogg | Sep 15, 2017 at 9:10 AM EDT

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

The top analyst upgrades, downgrades and other research calls from Friday include AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle,…

Chris Lange | Sep 13, 2017 at 8:40 AM EDT

Major Pharma Short Interest Surges

The August 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Sep 7, 2017 at 10:35 AM EDT

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Eli Lilly is cutting about 8% of its global workforce in a "streamlining and focusing" effort as part of a…

Chris Lange | Aug 25, 2017 at 9:55 AM EDT

Short Sellers Run for Cover From Major Pharma

The August 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Aug 10, 2017 at 8:40 AM EDT

Short Sellers Hike Bets in Major Pharma

The July 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jul 26, 2017 at 9:10 AM EDT

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

The top analyst upgrades, downgrades and other research calls from Wednesday include BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald's,…

Chris Lange | Jul 26, 2017 at 8:55 AM EDT

Major Pharma Short Interest Takes a Big Step Back

The July 14 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 21, 2017 at 8:37 AM EDT

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

Major pharmaceutical companies have posted a relatively positive year so far. Currently, Johnson & Johnson (NYSE: JNJ) is leading the…

Lee Jackson | Jul 19, 2017 at 9:42 AM EDT

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the…

Chris Lange | Jul 13, 2017 at 9:20 AM EDT

Major Pharma Short Sellers Become More Selective

The June 30 short interest data have been compared with the previous figures, and short interest moves in these selected…

1 … 24 25 26 27 28 … 45

Eli Lilly : LLY

All Eli Lilly Articles

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here’s the Math Retirees Miss.

4 ETFs Paying 4%+ Yields While Most Investors Chase the S&P 500

Forget SCHD. The Active Fund Wall Street’s Biggest Manager Runs Has Beaten It Since February 2022

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here's the Math Retirees Miss.

Laid Off at 60 With $700,000 Saved, He Found a Rare Roth Conversion Window Before Social Security Starts.

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here’s the Math Retirees Miss.

Eli Lilly : LLY

All Eli Lilly Articles

Will Eli Lilly’s mRNA Cancer Vaccine Investment Hit Paydirt?

Short Sellers Run for Cover From Major Pharma

Top Analyst Upgrades and Downgrades: Alphabet, Check Point, Chesapeake Energy, Chevron, Intel, MannKind, Schlumberger, Transocean and More

Major Pharma Short Interest Piles On

The List of Failed Alzheimer’s Drug Treatments Keeps Growing

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Major Pharma Short Interest Surges

Eli Lilly Hopes to Benefit From Joining the Layoff Brigade — 3,500 Pink Slips!

Short Sellers Run for Cover From Major Pharma

Short Sellers Hike Bets in Major Pharma

Top Analyst Upgrades and Downgrades: BP, Chipotle, Citigroup, Electronic Arts, Eli Lilly, McDonald’s, Texas Instruments, US Steel and More

Major Pharma Short Interest Takes a Big Step Back

Why Credit Suisse Prefers Johnson & Johnson Over Pfizer

SunTrust Says Big Pharmaceuticals Have Multiple Catalysts for the Rest of 2017

Major Pharma Short Sellers Become More Selective

Live Nasdaq Composite: Stocks Slip as Oil Climbs, Big Tech Earnings Take Spotlight

Live: Will Tesla Crush Tonight’s Q2 Earnings After Big Delivery Volume Beat?

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here’s the Math Retirees Miss.

4 ETFs Paying 4%+ Yields While Most Investors Chase the S&P 500

Forget SCHD. The Active Fund Wall Street’s Biggest Manager Runs Has Beaten It Since February 2022

Featured Reads

A $1 Million 401(k) Is Really Worth About $760,000 After Taxes. Here's the Math Retirees Miss.

Laid Off at 60 With $700,000 Saved, He Found a Rare Roth Conversion Window Before Social Security Starts.